
|Articles|October 3, 2008
Anika Therapeutics announces Canadian distribution agreement for Elevess
Bedford, Mass. - Anika Therapeutics has signed an agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.
Advertisement
Bedford, Mass.
- Anika Therapeutics has signed an exclusive agreement with Canderm Pharma, a skincare company in Canada, to distribute and market Elevess throughout Canada, BusinessWire reports.
Elevess is the first hyaluronic acid filler with lidocaine to be approved by the U.S. Food and Drug Administration.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















